DJIA 18,199.33 -15.09 -0.08%
NASDAQ 4,986.99 -0.90 -0.02%
S&P 500 2,111.07 0.33 0.02%
market minute promo

8.23 0.06 (0.73%)

REAL-TIME: Last trade at

company name or ticker

Recent Quotes

ARIA $8.23 0.73%
Company Photos
(Click to zoom)
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $8.18
Previous Close $8.17
Daily Range $8.07 - $8.35
52-Week Range $4.90 - $9.13
Market Cap $1.5B
P/E Ratio -9.39
Dividend (Yield) $0.00 (0.0%)
Volume 1,689,255
Average Daily Volume 6,745,122
Current FY EPS -$1.04




Drug Makers

Ariad Pharmaceuticals, Inc. (ARIA) Description

The Company is engaged in the discovery and development of breakthrough medicines to treat cancers by regulating cell signaling with small molecules. Website:

News & Commentary

Why Ariad Pharmaceuticals, Inc. Stock Soared Higher Today

Ariad Pharmaceuticals shares are jumping following its earnings yesterday and news of an upcoming proxy fight.

Interesting ARIA Call Options For April 10th

What Sarissa Capital's Proxy Fight Means For Ariad Investors

JMP Feeling Mostly Good On 4 Drug, Healthcare Stocks

Seeking Alpha's Biotech Weekly: Sanofi's New Chief, Sarissa Shakes Ariad, And More

Friday's ETF with Unusual Volume: PTH

Technical Breakout In Ariad Pharmaceuticals

Activist Hedge Fund Seeks Firing of Ariad Pharma CEO Berger

ARIAD Pharmaceuticals (ARIA) Harvey J. Berger on Q4 2014 Results - Earnings Call Transcript

ARIAD (ARIA) Posts Narrower-than-Expected Q4 Loss - Tale of the Tape

ARIAD (ARIA) Posts Narrower-than-Expected Q4 Loss - Tale of the Tape

See More ARIA News...

ARIA's Top Competitors

ARIA $8.23 (0.73%)
Current stock: ARIA
AMGN $157.82 (-0.72%)
Current stock: AMGN
GILD $103.29 (-0.86%)
Current stock: GILD
BIIB $409.22 (-0.21%)
Current stock: BIIB